Trump unveils Regeneron deal to lower drug prices

President Trump announced a voluntary price-cutting agreement with drugmaker Regeneron under the White House’s 'most favored nation' plan to align U.S. drug costs with those of other developed nations. Regeneron will reduce prices for its current and future medications sold in the U.S.